{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:27Z","timestamp":1793316567358,"version":"4.5.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DBT Ramalingaswami Re-entry Fellowship","award":["BT\/RLF\/Re-entry\/44\/2018"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/44\/2018"]}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/001213"],"award-info":[{"award-number":["CRG\/2020\/001213"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VIT SEED Grant","award":["2020-2021"],"award-info":[{"award-number":["2020-2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11010-022-04601-2","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:06:11Z","timestamp":1668701171000},"page":"1487-1518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19"],"prefix":"10.1007","volume":"478","author":[{"given":"Dhanashree","family":"Murugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loganathan","family":"Rangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"4601_CR1","unstructured":"WHO Coronavirus (COVID-19) Dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. (2021). https:\/\/covid19.who.int\/. Accessed 27 Apr 2021"},{"key":"4601_CR2","doi-asserted-by":"publisher","DOI":"10.18235\/0002451","author":"NL Bottan","year":"2020","unstructured":"Bottan NL, Vera-Cossio DA, Hoffmann B (2020) The unequal impact of the coronavirus pandemic: evidence from seventeen developing countries. PLoS ONE. https:\/\/doi.org\/10.18235\/0002451","journal-title":"PLoS ONE"},{"key":"4601_CR3","unstructured":"U.C. Bureau (2021) Initial impact of COVID-19 on U.S. economy more widespread than on mortality"},{"key":"4601_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.020","author":"I Astuti","year":"2020","unstructured":"Astuti I (2020) Ysrafil, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.020","journal-title":"Diabetes Metab Syndr"},{"key":"4601_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0400-4","author":"W Tai","year":"2020","unstructured":"Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-020-0400-4","journal-title":"Cell Mol Immunol"},{"key":"4601_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102115","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhao S (2020) Furin cleavage sites naturally occur in coronaviruses. Stem Cell Res. https:\/\/doi.org\/10.1016\/j.scr.2020.102115","journal-title":"Stem Cell Res"},{"key":"4601_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","volume":"100","author":"G Simmons","year":"2013","unstructured":"Simmons G, Zmora P, Gierer S, Heurich A, P\u00f6hlmann S (2013) Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antivir Res 100:605\u2013614. https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.028","journal-title":"Antivir Res"},{"key":"4601_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105982","volume":"175","author":"A Villa","year":"2022","unstructured":"Villa A, Brunialti E, Dellavedova J, Meda C, Rebecchi M, Conti M, Donnici L, De Francesco R, Reggiani A, Lionetti V, Ciana P (2022) DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Pharmacol Res 175:105982. https:\/\/doi.org\/10.1016\/j.phrs.2021.105982","journal-title":"Pharmacol Res"},{"key":"4601_CR9","unstructured":"Computational comparison of SARS-CoV-2 Delta and Omicron variant binding affinity with ACE2. (2021). https:\/\/www.news-medical.net\/news\/20211208\/Computational-comparison-of-SARS-CoV-2-Delta-and-Omicron-variant-binding-affinity-with-ACE2.aspx. Accessed 24 Jan 2022"},{"key":"4601_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.27526","author":"S Kumar","year":"2021","unstructured":"Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G (2021) Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol. https:\/\/doi.org\/10.1002\/JMV.27526","journal-title":"J Med Virol"},{"key":"4601_CR11","unstructured":"ACE2 angiotensin I converting enzyme 2 [Homo sapiens (human)]\u2014Gene\u2014NCBI. (2018). https:\/\/www.ncbi.nlm.nih.gov\/gene\/59272#gene-expression. Accessed 10 Sept 2020"},{"key":"4601_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321195","author":"SC Ng","year":"2020","unstructured":"Ng SC, Tilg H (2020) COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2020-321195","journal-title":"Gut"},{"key":"4601_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730088","author":"L Francistiov\u00e1","year":"2021","unstructured":"Francistiov\u00e1 L, Klepe A, Curley G, Gulya K, Dinny\u00e9s A, Filkor K (2021) Cellular and molecular effects of SARS-CoV-2 linking lung infection to the brain. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.730088","journal-title":"Front Immunol"},{"key":"4601_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.701278","author":"F Liu","year":"2021","unstructured":"Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, W\u00f6rsd\u00f6rfer P, Midkiff CC, Mudd J, Belyaeva E, Milligan NS, Rorison TD, Wagner N, Bodem J, D\u00f6lken L, Aktas BH, Vander Heide RS, Yin X-M, Kolls JK, Roy CJ, Rappaport J, Erg\u00fcn S, Qin X (2021) SARS-CoV-2 infects endothelial cells in vivo and in vitro. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2021.701278","journal-title":"Front Cell Infect Microbiol"},{"key":"4601_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/d41586-021-01693-6","volume":"595","author":"M Marshall","year":"2021","unstructured":"Marshall M (2021) COVID and the brain: researchers zero in on how damage occurs. Nature 595:484\u2013485. https:\/\/doi.org\/10.1038\/d41586-021-01693-6","journal-title":"Nature"},{"key":"4601_CR16","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S2665-9913(20)30120-X","volume":"2","author":"J Zhong","year":"2020","unstructured":"Zhong J, Tang J, Ye C, Dong L (2020) The immunology of COVID-19: is immune modulation an option for treatment? Lancet Rheumatol 2:e428\u2013e436. https:\/\/doi.org\/10.1016\/S2665-9913(20)30120-X","journal-title":"Lancet Rheumatol"},{"key":"4601_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00434-6","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z (2020) Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-00434-6","journal-title":"Nat Rev Immunol"},{"key":"4601_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","volume":"10","author":"IY Chen","year":"2019","unstructured":"Chen IY, Moriyama M, Chang MF, Ichinohe T (2019) Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol 10:50. https:\/\/doi.org\/10.3389\/fmicb.2019.00050","journal-title":"Front Microbiol"},{"key":"4601_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","volume":"33","author":"S Tian","year":"2020","unstructured":"Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao SY (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33:1007\u20131014. https:\/\/doi.org\/10.1038\/s41379-020-0536-x","journal-title":"Mod Pathol"},{"key":"4601_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3978\/j.issn.2072-1439.2013.04.05","volume":"5","author":"V Fanelli","year":"2013","unstructured":"Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H (2013) Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis 5:326\u2013334. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.04.05","journal-title":"J Thorac Dis"},{"key":"4601_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S2213-2600(21)00105-3","volume":"9","author":"MA Matthay","year":"2021","unstructured":"Matthay MA, Thompson BT, Ware LB (2021) The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included? Lancet Respir Med 9:933\u2013936. https:\/\/doi.org\/10.1016\/S2213-2600(21)00105-3","journal-title":"Lancet Respir Med"},{"key":"4601_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/17476348.2022.2057300","volume":"16","author":"L Ball","year":"2022","unstructured":"Ball L, Silva PL, Giacobbe DR, Bassetti M, Zubieta-Calleja GR, Rocco PRM, Pelosi P (2022) Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19. Expert Rev Respir Med 16:437\u2013446. https:\/\/doi.org\/10.1080\/17476348.2022.2057300","journal-title":"Expert Rev Respir Med"},{"key":"4601_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155151","volume":"133","author":"M Mahmudpour","year":"2020","unstructured":"Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I (2020) COVID-19 cytokine storm: the anger of inflammation. Cytokine 133:155151. https:\/\/doi.org\/10.1016\/j.cyto.2020.155151","journal-title":"Cytokine"},{"key":"4601_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jocit.2014.12.001","volume":"2","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Ren H, Han Z (2016) Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases. J Cell Immunother 2:3\u201320. https:\/\/doi.org\/10.1016\/j.jocit.2014.12.001","journal-title":"J Cell Immunother"},{"key":"4601_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.biotechadv.2012.11.006","volume":"31","author":"VW Wong","year":"2013","unstructured":"Wong VW, Sorkin M, Gurtner GC (2013) Enabling stem cell therapies for tissue repair: current and future challenges. Biotechnol Adv 31:744\u2013751. https:\/\/doi.org\/10.1016\/j.biotechadv.2012.11.006","journal-title":"Biotechnol Adv"},{"key":"4601_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-018-0866-5","volume":"9","author":"C Laowtammathron","year":"2018","unstructured":"Laowtammathron C, Chingsuwanrote P, Choavaratana R, Phornwilardsiri S, Sitthirit K, Kaewjunun C, Makemaharn O, Terbto P, Waeteekul S, Lorthongpanich C, U-Pratya Y, Srisook P, Kheolamai P, Issaragrisil S (2018) High-efficiency derivation of human embryonic stem cell lines using a culture system with minimized trophoblast cell proliferation. Stem Cell Res Ther 9:138. https:\/\/doi.org\/10.1186\/s13287-018-0866-5","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.22037\/ghfbb.v0i0.1089","volume":"10","author":"K Baghaei","year":"2017","unstructured":"Baghaei K, Hashemi SM, Tokhanbigli S, Rad AA, Assadzadeh-Aghdaei H, Sharifian A, Zali MR (2017) Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterol Hepatol Bed Bench 10:208\u2013213. https:\/\/doi.org\/10.22037\/ghfbb.v0i0.1089","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"4601_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12861-015-0065-x","volume":"15","author":"A Pisciotta","year":"2015","unstructured":"Pisciotta A, Carnevale G, Meloni S, Riccio M, De Biasi S, Gibellini L, Ferrari A, Bruzzesi G, De Pol A (2015) Human dental pulp stem cells (hDPSCs): isolation, enrichment and comparative differentiation of two sub-populations Integrative control of development. BMC Dev Biol 15:14. https:\/\/doi.org\/10.1186\/s12861-015-0065-x","journal-title":"BMC Dev Biol"},{"key":"4601_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/916136","author":"C Mennan","year":"2013","unstructured":"Mennan C, Wright K, Bhattacharjee A, Balain B, Richardson J, Roberts S (2013) Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. BioMed Res Int. https:\/\/doi.org\/10.1155\/2013\/916136","journal-title":"BioMed Res Int"},{"key":"4601_CR30","doi-asserted-by":"publisher","first-page":"54204","DOI":"10.3791\/54204","volume":"2016","author":"RA Pelekanos","year":"2016","unstructured":"Pelekanos RA, Sardesai VS, Futrega K, Lott WB, Kuhn M, Doran MR (2016) Isolation and expansion of mesenchymal stem\/stromal cells derived from human placenta tissue. J Vis Exp 2016:54204. https:\/\/doi.org\/10.3791\/54204","journal-title":"J Vis Exp"},{"key":"4601_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5932706","author":"LS Spitzhorn","year":"2017","unstructured":"Spitzhorn LS, Rahman MS, Schwindt L, Ho HT, Wruck W, Bohndorf M, Wehrmeyer S, Ncube A, Beyer I, Hagenbeck C, Balan P (2017) Isolation and molecular characterization of amniotic fluid-derived mesenchymal stem cells obtained from caesarean sections. Stem Cells Int. https:\/\/doi.org\/10.1155\/2017\/5932706","journal-title":"Stem Cells Int"},{"key":"4601_CR32","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.2848","author":"M Call","year":"2018","unstructured":"Call M, Meyer E, Kao W, Kruse F, Schloetzer-Schredhardt U (2018) Hair follicle stem cell isolation and expansion. Bio-Protocol. https:\/\/doi.org\/10.21769\/bioprotoc.2848","journal-title":"Bio-Protocol"},{"key":"4601_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13287-018-0932-z","volume":"9","author":"N Pavathuparambil Abdul Manaph","year":"2018","unstructured":"Pavathuparambil Abdul Manaph N, Al-Hawaas M, Bobrovskaya L, Coates PT, Zhou XF (2018) Urine-derived cells for human cell therapy. Stem Cell Res Ther 9:189. https:\/\/doi.org\/10.1186\/s13287-018-0932-z","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR34","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/stem.1188","volume":"30","author":"F Hassiotou","year":"2012","unstructured":"Hassiotou F, Beltran A, Chetwynd E, Stuebe AM, Twigger AJ, Metzger P, Trengove N, Lai CL, Filgueira L, Blancafort P, Hartmann PE (2012) Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells 30:2164\u20132174. https:\/\/doi.org\/10.1002\/stem.1188","journal-title":"Stem Cells"},{"key":"4601_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100454","author":"F S\u00e1nchez-Guijo","year":"2020","unstructured":"S\u00e1nchez-Guijo F, Garc\u00eda-Arranz M, L\u00f3pez-Parra M, Monedero P, Mata-Mart\u00ednez C, Santos A, Sagredo V, \u00c1lvarez-Avello J-M, Guerrero JE, P\u00e9rez-Calvo C, S\u00e1nchez-Hern\u00e1ndez M-V, Del-Pozo JL, Andreu EJ, Fern\u00e1ndez-Santos M-E, Soria-Juan B, Hern\u00e1ndez-Blasco LM, Andreu E, Sempere JM, Zapata AG, Moraleda JM, Soria B, Fern\u00e1ndez-Avil\u00e9s F, Garc\u00eda-Olmo D, Pr\u00f3sper F (2020) Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100454","journal-title":"EClinicalMedicine"},{"key":"4601_CR36","unstructured":"Treatment of Covid-19 associated pneumonia with allogenic pooled olfactory mucosa-derived mesenchymal stem cells\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04382547?term=stem+cell&cond=sars-cov-2&draw=2&rank=13. Accessed 23 Aug 2020"},{"key":"4601_CR37","unstructured":"Using human menstrual blood cells to treat acute lung injury caused by H7N9 bird flu virus infection\u2014full text view\u2014ClinicalTrials.gov. (2014). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02095444?term=NCT02095444&draw=2&rank=1. Accessed 20 Sept 2020"},{"key":"4601_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13287-020-01802-8","volume":"11","author":"H Peng","year":"2020","unstructured":"Peng H, Gong T, Huang X, Sun X, Luo H, Wang W, Luo J, Luo B, Chen Y, Wang X, Long H, Mei H, Li C, Dai Y, Li H (2020) A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report. Stem Cell Res Ther 11:291. https:\/\/doi.org\/10.1186\/s13287-020-01802-8","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4252\/wjsc.v7.i1.116","volume":"7","author":"T Seki","year":"2015","unstructured":"Seki T (2015) Methods of induced pluripotent stem cells for clinical application. World J Stem Cells 7:116. https:\/\/doi.org\/10.4252\/wjsc.v7.i1.116","journal-title":"World J Stem Cells"},{"key":"4601_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.addr.2007.08.036","volume":"60","author":"NS Hwang","year":"2008","unstructured":"Hwang NS, Varghese S, Elisseeff J (2008) Controlled differentiation of stem cells. Adv Drug Deliv Rev 60:199\u2013214. https:\/\/doi.org\/10.1016\/j.addr.2007.08.036","journal-title":"Adv Drug Deliv Rev"},{"key":"4601_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3057624","author":"M Wang","year":"2018","unstructured":"Wang M, Yuan Q, Xie L (2018) Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int. https:\/\/doi.org\/10.1155\/2018\/3057624","journal-title":"Stem Cells Int"},{"key":"4601_CR42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/jcm8071025","volume":"8","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Yamamoto Y, Xiao Z, Ochiya T (2019) The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity. J Clin Med 8:1025. https:\/\/doi.org\/10.3390\/jcm8071025","journal-title":"J Clin Med"},{"key":"4601_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/stem.2254","volume":"34","author":"P Luz-Crawford","year":"2016","unstructured":"Luz-Crawford P, Djouad F, Toupet K, Bony C, Franquesa M, Hoogduijn MJ, Jorgensen C, No\u00ebl D (2016) Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation. Stem Cells 34:483\u2013492. https:\/\/doi.org\/10.1002\/stem.2254","journal-title":"Stem Cells"},{"key":"4601_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01191","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH (2019) Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01191","journal-title":"Front Immunol"},{"key":"4601_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3248605","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Ge XH, Guo XJ, Bin Guan S, Li XM, Gu W, Xu WG (2017) Bone marrow mesenchymal stem cells inhibit the function of dendritic cells by secreting galectin-1. BioMed Res Int. https:\/\/doi.org\/10.1155\/2017\/3248605","journal-title":"BioMed Res Int"},{"key":"4601_CR46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/stem.3151","volume":"38","author":"N Negi","year":"2020","unstructured":"Negi N, Griffin MD (2020) Effects of mesenchymal stromal cells on regulatory T cells: current understanding and clinical relevance. Stem Cells 38:596\u2013605. https:\/\/doi.org\/10.1002\/stem.3151","journal-title":"Stem Cells"},{"key":"4601_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4252\/wjsc.v11.i9.604","volume":"11","author":"O Andrukhov","year":"2019","unstructured":"Andrukhov O, Behm C, Blufstein A, Rausch-Fan X (2019) Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: implication in disease and tissue regeneration. World J Stem Cells 11:604\u2013617. https:\/\/doi.org\/10.4252\/wjsc.v11.i9.604","journal-title":"World J Stem Cells"},{"key":"4601_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cellimm.2016.08.008","volume":"310","author":"AT \u00d6zdemir","year":"2016","unstructured":"\u00d6zdemir AT, \u00d6zg\u00fcl \u00d6zdemir RB, K\u0131rmaz C, Sar\u0131boyac\u0131 AE, \u00dcnal Halbuto\u011fllar\u0131 ZS, \u00d6zel C, Kara\u00f6z E (2016) The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol 310:108\u2013115. https:\/\/doi.org\/10.1016\/j.cellimm.2016.08.008","journal-title":"Cell Immunol"},{"key":"4601_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13287-017-0659-2","volume":"8","author":"VG Martinez","year":"2017","unstructured":"Martinez VG, Ontoria-Oviedo I, Ricardo CP, Harding SE, Sacedon R, Varas A, Zapata A, Sepulveda P, Vicente A (2017) Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells. Stem Cell Res Ther 8:208. https:\/\/doi.org\/10.1186\/s13287-017-0659-2","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60663-3","author":"KH Grinnemo","year":"2006","unstructured":"Grinnemo KH, Kumagai-Braesch M, M\u00e5nsson-Broberg A, Skottman H, Hao X, Siddiqui A, Andersson A, Str\u00f6mberg AM, Lahesmaa R, Hovatta O, Sylven C, Corbascio M, Dellgren G (2006) Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online. https:\/\/doi.org\/10.1016\/S1472-6483(10)60663-3","journal-title":"Reprod Biomed Online"},{"key":"4601_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2020.00054","volume":"11","author":"M Bulati","year":"2020","unstructured":"Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, Conaldi PG (2020) The immunomodulatory properties of the human amnion-derived mesenchymal stromal\/stem cells are induced by INF-\u03b3 produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Front Immunol 11:54. https:\/\/doi.org\/10.3389\/fimmu.2020.00054","journal-title":"Front Immunol"},{"key":"4601_CR52","doi-asserted-by":"publisher","first-page":"sctm.18-0260","DOI":"10.1002\/sctm.18-0260","volume":"8","author":"D Perlee","year":"2019","unstructured":"Perlee D, Vos AF, Scicluna BP, Manche\u00f1o P, Rosa O, Dalemans W, N\u00fcrnberg P, Lombardo E, Poll T (2019) Human adipose-derived mesenchymal stem cells modify lung immunity and improve antibacterial defense in pneumosepsis caused by Klebsiella pneumoniae. Stem Cells Transl Med 8:sctm.18-0260. https:\/\/doi.org\/10.1002\/sctm.18-0260","journal-title":"Stem Cells Transl Med"},{"key":"4601_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/infdis\/jiy478","volume":"219","author":"H Loy","year":"2019","unstructured":"Loy H, Kuok DIT, Hui KPY, Choi MHL, Yuen W, Nicholls JM, Peiris JSM, Chan MCW (2019) Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury. J Infect Dis 219:186\u2013196. https:\/\/doi.org\/10.1093\/infdis\/jiy478","journal-title":"J Infect Dis"},{"key":"4601_CR54","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3727\/096368911x565038a","volume":"20","author":"YS Chang","year":"2011","unstructured":"Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, Park WS (2011) Intratracheal transplantation of human umbilical cordblood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 20:1843\u20131854. https:\/\/doi.org\/10.3727\/096368911x565038a","journal-title":"Cell Transplant"},{"key":"4601_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12522","author":"DK Sung","year":"2016","unstructured":"Sung DK, Chang YS, Sung SI, Yoo HS, Ahn SY, Park WS (2016) Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta-defensin-2 via toll-like receptor 4 signalling. Cell Microbiol. https:\/\/doi.org\/10.1111\/cmi.12522","journal-title":"Cell Microbiol"},{"key":"4601_CR56","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/thoraxjnl-2015-206813","volume":"70","author":"J Devaney","year":"2015","unstructured":"Devaney J, Horie S, Masterson C, Elliman S, Barry F, O\u2019Brien T, Curley GF, O\u2019Toole D, Laffey JG (2015) Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 70:625\u2013635. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-206813","journal-title":"Thorax"},{"key":"4601_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.intimp.2018.06.036","volume":"63","author":"Z Huang","year":"2018","unstructured":"Huang Z, Liu H, Zhang X, Wen G, Zhu C, Zhao Y, Niu W, Qin Y, Chen H, Bai C, Liu G (2018) Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models. Int Immunopharmacol 63:26\u201334. https:\/\/doi.org\/10.1016\/j.intimp.2018.06.036","journal-title":"Int Immunopharmacol"},{"key":"4601_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18040689","volume":"18","author":"B Xiang","year":"2017","unstructured":"Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C (2017) Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of lps-induced acute lung injury. Int J Mol Sci 18:1\u201316. https:\/\/doi.org\/10.3390\/ijms18040689","journal-title":"Int J Mol Sci"},{"key":"4601_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0802-8","volume":"9","author":"LHA Silva","year":"2018","unstructured":"Silva LHA, Antunes MA, Dos Santos CC, Weiss DJ, Cruz FF, Rocco PRM (2018) Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases. Stem Cell Res Ther 9:1\u20139. https:\/\/doi.org\/10.1186\/s13287-018-0802-8","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10753-018-0884-6","volume":"42","author":"L Wang","year":"2019","unstructured":"Wang L, Shi M, Tong L, Wang J, Ji S, Bi J, Chen C, Jiang J, Bai C, Zhou J, Song Y (2019) Lung-resident mesenchymal stem cells promote repair of LPS-induced acute lung injury via regulating the balance of regulatory T cells and Th17 cells. Inflammation 42:199\u2013210. https:\/\/doi.org\/10.1007\/s10753-018-0884-6","journal-title":"Inflammation"},{"key":"4601_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2272-x","volume":"22","author":"MR Mokhber Dezfouli","year":"2018","unstructured":"Mokhber Dezfouli MR, Jabbari Fakhr M, Sadeghian Chaleshtori S, Dehghan MM, Vajhi A, Mokhtari R (2018) Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit. Crit Care 22:1\u201313. https:\/\/doi.org\/10.1186\/s13054-018-2272-x","journal-title":"Crit Care"},{"key":"4601_CR62","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"MV Jackson","year":"2016","unstructured":"Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, O\u2019Kane CM, Krasnodembskaya AD (2016) Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 34:2210\u20132223. https:\/\/doi.org\/10.1002\/stem.2372","journal-title":"Stem Cells"},{"key":"4601_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-016-0395-z","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Xu J, Shi W, Chen C, Shao Y, Zhu L, Lu W, Han XD (2016) Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice. Stem Cell Res Ther 7:1\u201311. https:\/\/doi.org\/10.1186\/s13287-016-0395-z","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR64","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1073\/pnas.1601911113","volume":"113","author":"MCW Chan","year":"2016","unstructured":"Chan MCW, Kuok DIT, Leung CYH, Hui KPY, Valkenburg SA, Lau EHY, Nicholls JM, Fang X, Guan Y, Lee JW, Chan RWY, Webster RG, Matthay MA, Peiris JSM (2016) Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci USA 113:3621\u20133626. https:\/\/doi.org\/10.1073\/pnas.1601911113","journal-title":"Proc Natl Acad Sci USA"},{"key":"4601_CR65","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K (2019) Macrophage polarization: different gene signatures in M1(Lps+) vs. classically and M2(LPS\u2212) vs. alternatively activated macrophages. Front Immunol 10:1084. https:\/\/doi.org\/10.3389\/fimmu.2019.01084","journal-title":"Front Immunol"},{"key":"4601_CR66","unstructured":"Surgery C, Institutet K, Cell S, Mass P, Surgery C (2015) Tissue engineering and regenerative medicine in vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. 1199\u20131213"},{"key":"4601_CR67","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","volume":"7","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD (2019) Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med 7:154\u2013162. https:\/\/doi.org\/10.1016\/S2213-2600(18)30418-1","journal-title":"Lancet Respir Med"},{"key":"4601_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-15-39","volume":"15","author":"G Zheng","year":"2014","unstructured":"Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge M, Deng K, Zhang L, Zou B, Cheng B, Xu J (2014) Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res 15:1\u201310. https:\/\/doi.org\/10.1186\/1465-9921-15-39","journal-title":"Respir Res"},{"key":"4601_CR69","doi-asserted-by":"publisher","unstructured":"Bellingan G, Jacono F, Bannard-Smith J, Brealey D, Meyer N, Thickett D, Young D, Bentley A, McVerry B, Wunderink RG, Doerschug KC, Summers C, Rojas M, Jenkins ED, Ting A (2019) Primary analysis of a phase 1\/2 study to assess MultiStem\u00ae cell therapy, a regenerative advanced therapy medicinal product (ATMP), in acute respiratory distress syndrome (MUST-ARDS), vol 174, p A7353. https:\/\/doi.org\/10.1164\/ajrccm-conference.2019.199.1_meetingabstracts.a7353","DOI":"10.1164\/ajrccm-conference.2019.199.1_meetingabstracts.a7353"},{"key":"4601_CR70","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/scd.2020.0071","volume":"29","author":"RC Zhao","year":"2020","unstructured":"Zhao RC (2020) Stem cell-based therapy for coronavirus disease 2019. Stem Cells Dev 29:679\u2013681. https:\/\/doi.org\/10.1089\/scd.2020.0071","journal-title":"Stem Cells Dev"},{"key":"4601_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.17.20024166","author":"Y Liu","year":"2020","unstructured":"Liu Y, Sun W, Li J, Chen L, Wang Y, Zhang L, Yu L (2020) Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019. medRxiv. https:\/\/doi.org\/10.1101\/2020.02.17.20024166","journal-title":"medRxiv"},{"key":"4601_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.02.006","author":"J Chen","year":"2020","unstructured":"Chen J, Hu C, Chen L, Tang L, Zhu Y, Xu X, Chen L, Gao H, Lu X, Yu L, Dai X, Xiang C, Li L (2020) Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment. Engineering. https:\/\/doi.org\/10.1016\/j.eng.2020.02.006","journal-title":"Engineering"},{"key":"4601_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/sctm.19-0037","volume":"9","author":"A Averyanov","year":"2020","unstructured":"Averyanov A, Koroleva I, Konoplyannikov M, Revkova V, Lesnyak V, Kalsin V, Danilevskaya O, Nikitin A, Sotnikova A, Kotova S, Baklaushev V (2020) First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med 9:6\u201316. https:\/\/doi.org\/10.1002\/sctm.19-0037","journal-title":"Stem Cells Transl Med"},{"key":"4601_CR74","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0044-2017","author":"S Geiger","year":"2017","unstructured":"Geiger S, Hirsch D, Hermann FG (2017) Cell therapy for lung disease. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0044-2017","journal-title":"Eur Respir Rev"},{"key":"4601_CR75","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14760584.2021.1976153","volume":"20","author":"L Bian","year":"2021","unstructured":"Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, Mao Q, Xu M, Liang Z (2021) Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines 20:1201\u20131209. https:\/\/doi.org\/10.1080\/14760584.2021.1976153","journal-title":"Expert Rev Vaccines"},{"key":"4601_CR76","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s13063-020-04380-5","volume":"21","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y (2020) Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I\/II). Trials 21:520. https:\/\/doi.org\/10.1186\/s13063-020-04380-5","journal-title":"Trials"},{"key":"4601_CR77","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13287-021-02482-8","volume":"12","author":"A Safari","year":"2021","unstructured":"Safari A, Lionetti V, Razeghian-Jahromi I (2021) Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction. Stem Cell Res Ther 12:404. https:\/\/doi.org\/10.1186\/s13287-021-02482-8","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR78","unstructured":"Search of: stem cells and COVID\u2014list results\u2014ClinicalTrials.gov. (2022). https:\/\/clinicaltrials.gov\/ct2\/results?cond=stem+cells+AND+COVID&term=&cntry=&state=&city=&dist=. Accessed 24 Jan 2022"},{"key":"4601_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.intimp.2012.03.024","volume":"13","author":"JM Lee","year":"2012","unstructured":"Lee JM, Jung J, Lee H-J, Jeong SJ, Cho KJ, Hwang S-G, Kim GJ (2012) Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 13:219\u2013224. https:\/\/doi.org\/10.1016\/j.intimp.2012.03.024","journal-title":"Int Immunopharmacol"},{"key":"4601_CR80","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10561-021-09914-y","volume":"22","author":"A Pisula","year":"2021","unstructured":"Pisula A, Sienicka A, Stachyra K, Kacperczyk-Bartnik J, Bartnik P, Dobrowolska-Redo A, Romejko-Wolniewicz E (2021) Women\u2019s attitude towards umbilical cord blood banking in Poland. Cell Tissue Bank 22:587\u2013596. https:\/\/doi.org\/10.1007\/s10561-021-09914-y","journal-title":"Cell Tissue Bank"},{"key":"4601_CR81","first-page":"E71","volume":"23","author":"S Atluri","year":"2020","unstructured":"Atluri S, Manchikanti L, Hirsch JA (2020) Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ILL COVID-19 patients: the case for compassionate use. Pain Physician 23:E71\u2013E84","journal-title":"Pain Physician"},{"key":"4601_CR82","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-020-0795-1","volume":"115","author":"S Singh","year":"2020","unstructured":"Singh S, Chakravarty T, Chen P, Akhmerov A, Falk J, Friedman O, Zaman T, Ebinger JE, Gheorghiu M, Marb\u00e1n L, Marb\u00e1n E, Makkar RR (2020) Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series. Basic Res Cardiol 115:36. https:\/\/doi.org\/10.1007\/s00395-020-0795-1","journal-title":"Basic Res Cardiol"},{"key":"4601_CR83","unstructured":"Role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04349540?term=stem+cell&cond=sars-cov-2&draw=2&rank=22. Accessed 23 Aug 2020"},{"key":"4601_CR84","unstructured":"Stem cell educator therapy treat the viral inflammation in COVID-19\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04299152?term=stem+cell&cond=sars-cov-2&draw=2&rank=26. Accessed 23 Aug 2020"},{"key":"4601_CR85","unstructured":"Safety and efficacy of CAStem for severe COVID-19 associated with\/without ARDS\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04331613?term=stem+cell&cond=sars-cov-2&draw=2&rank=49. Accessed 23 Aug 2020"},{"key":"4601_CR86","unstructured":"Treatment of coronavirus COVID-19 pneumonia (pathogen SARS-CoV-2) with cryopreserved allogeneic P_MMSCs and UC-MMSCs\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04461925?term=stem+cell&cond=sars-cov-2&draw=2&rank=31. Accessed 23 Aug 2020"},{"key":"4601_CR87","unstructured":"A study of cell therapy in COVID-19 subjects with acute kidney injury who are receiving renal replacement therapy\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04445220?term=stem+cell&cond=sars-cov-2&draw=2&rank=63. Accessed 23 Aug 2020"},{"key":"4601_CR88","unstructured":"Novel coronavirus induced severe pneumonia treated by dental pulp mesenchymal stem cells\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04302519?term=stem+cell&cond=sars-cov-2&draw=2&rank=27. Accessed 23 Aug 2020"},{"key":"4601_CR89","unstructured":"Clinical trial to assess the safety and efficacy of intravenous administration of allogeneic adult mesenchymal stem cells of expanded adipose tissue in patients with severe pneumonia due to COVID-19\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04366323?term=stem+cell&cond=sars-cov-2&draw=2&rank=1. Accessed 21 Aug 2020"},{"key":"4601_CR90","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","volume":"29","author":"V Sengupta","year":"2020","unstructured":"Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N (2020) Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev 29:747\u2013754. https:\/\/doi.org\/10.1089\/scd.2020.0080","journal-title":"Stem Cells Dev"},{"key":"4601_CR91","unstructured":"A pilot clinical study on inhalation of mesenchymal stem cells exosomes treating severe novel coronavirus pneumonia\u2014no study results posted\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT04276987. Accessed 4 Aug 2020"},{"key":"4601_CR92","unstructured":"Evaluation of safety and efficiency of method of exosome inhalation in SARS-CoV-2 associated pneumonia\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04491240?term=stem+cell&cond=sars-cov-2&draw=2&rank=57. Accessed 23 Aug 2020"},{"key":"4601_CR93","unstructured":"Organicell flow for patients with COVID-19\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04384445?term=NCT04384445&draw=2&rank=1. Accessed 23 Aug 2020"},{"key":"4601_CR94","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41422-020-0369-7","volume":"30","author":"J Chen","year":"2020","unstructured":"Chen J, Wu H, Yu Y, Tang N (2020) Pulmonary alveolar regeneration in adult COVID-19 patients. Cell Res 30:708\u2013710. https:\/\/doi.org\/10.1038\/s41422-020-0369-7","journal-title":"Cell Res"},{"key":"4601_CR95","doi-asserted-by":"publisher","first-page":"462","DOI":"10.14336\/AD.2020.0301","volume":"11","author":"AK Shetty","year":"2020","unstructured":"Shetty AK (2020) Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia. Aging Dis 11:462\u2013464. https:\/\/doi.org\/10.14336\/AD.2020.0301","journal-title":"Aging Dis"},{"key":"4601_CR96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC (2020) Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia. Aging Dis 11:216\u2013228. https:\/\/doi.org\/10.14336\/AD.2020.0228","journal-title":"Aging Dis"},{"key":"4601_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01875-5","volume":"11","author":"L Shu","year":"2020","unstructured":"Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, Ji N, Zheng Y, Chen X, Shi L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J, Feng G (2020) Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther 11:1\u201311. https:\/\/doi.org\/10.1186\/s13287-020-01875-5","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00286-5","author":"F Meng","year":"2020","unstructured":"Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T, Huang L, Zhao P, Yuan X, Fan X, Zhang JY, Song J, Zhang D, Jiao Y, Liu L, Zhou C, Maeurer M, Zumla A, Shi M, Wang FS (2020) Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-020-00286-5","journal-title":"Signal Transduct Target Ther"},{"key":"4601_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0810-9","author":"L Tang","year":"2020","unstructured":"Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C, Ye P, Chen X, Wang B, Xu Z, Zhang Q, Xu X, Gao H, Wu X, Li D, Jiang W, Qu J, Xiang C, Li L (2020) Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19. Front Med. https:\/\/doi.org\/10.1007\/s11684-020-0810-9","journal-title":"Front Med"},{"key":"4601_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13287-020-01725-4","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, Meng M, Wu T, Liu D, Tian S, Tian H, Chen S, Zhou C (2020) Intravenous infusion of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res Ther 11:207. https:\/\/doi.org\/10.1186\/s13287-020-01725-4","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR101","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/scd.2018.0170","volume":"28","author":"R Oldershaw","year":"2019","unstructured":"Oldershaw R, Owens WA, Sutherland R, Linney M, Liddle R, Magana L, Lash GE, Gill JH, Richardson G, Meeson A (2019) Human cardiac-mesenchymal stem cell-like cells, a novel cell population with therapeutic potential. Stem Cells Dev 28:593\u2013607","journal-title":"Stem Cells Dev"},{"key":"4601_CR102","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","volume":"59","author":"TS Li","year":"2012","unstructured":"Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marb\u00e1n L, Marb\u00e1n E (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59:942\u2013953. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.029","journal-title":"J Am Coll Cardiol"},{"key":"4601_CR103","unstructured":"Pluristem reports preliminary data from its COVID-19 compassionate use program, treating seven patients with acute respiratory failure Nasdaq:PSTI. (2020). https:\/\/www.globenewswire.com\/news-release\/2020\/04\/07\/2012754\/0\/en\/Pluristem-Reports-Preliminary-Data-from-its-COVID-19-Compassionate-Use-Program-Treating-Seven-Patients-with-Acute-Respiratory-Failure.html. Accessed 22 Aug 2020"},{"key":"4601_CR104","unstructured":"Mesoblast reports 83% survival in ventilator-dependent COVID-19 patients following stem cell therapy | 2020-04-24 | BioWorld. (2020). https:\/\/www.bioworld.com\/articles\/434640-mesoblast-reports-83-survival-in-ventilator-dependent-covid-19-patients-following-stem-cell-therapy. Accessed 23 Aug 2020"},{"key":"4601_CR105","unstructured":"MultiStem administration for COVID-19 induced ARDS (MACoVIA)\u2014tabular view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04367077?term=stem+cell&cond=sars-cov-2&draw=2&rank=62. Accessed 23 Aug 2020"},{"key":"4601_CR106","unstructured":"Athersys, Inc.\u2014home. (2020). https:\/\/www.athersys.com\/home\/default.aspx. Accessed 23 Sept 2020"},{"key":"4601_CR107","unstructured":"Cynata therapeutics kicks off COVID-19 trial enrolment. (2020). https:\/\/www.outsourcing-pharma.com\/Article\/2020\/09\/09\/Cynata-Therapeutics-kicks-off-COVID-19-trial-enrollment. Accessed 23 Sept 2020"},{"key":"4601_CR108","unstructured":"Celltex therapeutics gets FDA nod for Phase II Covid-19 trial. (2020). https:\/\/www.clinicaltrialsarena.com\/news\/celltext-fda-nod-phaseii-trial\/. Accessed 23 Sept 2020"},{"key":"4601_CR109","unstructured":"The MEseNchymal coviD-19 trial: a pilot study to investigate early efficacy of MSCs in adults with COVID-19\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04537351?term=NCT04537351&draw=2&rank=1. Accessed 20 Sept 2020"},{"key":"4601_CR110","unstructured":"Autologous adipose-derived stem cells (AdMSCs) for COVID-19\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04428801?term=stem+cell&cond=sars-cov-2&draw=2&rank=4. Accessed 21 Aug 2020"},{"key":"4601_CR111","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.253522","volume":"14","author":"A Evangelista","year":"2019","unstructured":"Evangelista A, Soares MBP, Villarreal CF (2019) Cell-free therapy: a neuroregenerative approach to sensory neuropathy? Neural Regen Res 14:1383\u20131384. https:\/\/doi.org\/10.4103\/1673-5374.253522","journal-title":"Neural Regen Res"},{"key":"4601_CR112","doi-asserted-by":"publisher","first-page":"20200186","DOI":"10.1002\/VIW.20200186","volume":"2","author":"KD Popowski","year":"2021","unstructured":"Popowski KD, Dinh P-UC, George A, Lutz H, Cheng K (2021) Exosome therapeutics for COVID-19 and respiratory viruses. VIEW 2:20200186. https:\/\/doi.org\/10.1002\/VIW.20200186","journal-title":"VIEW"},{"key":"4601_CR113","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/jamp.2020.1622","volume":"33","author":"JP Mitchell","year":"2020","unstructured":"Mitchell JP, Berlinski A, Canisius S, Cipolla D, Dolovich MB, Gonda I, Hochhaus G, Kadrichu N, Lyapustina S, Mansour HM, Darquenne C, Clark AR, Newhouse M, Ehrmann S, Humphries R, Boushey H (2020) Urgent appeal from international society for aerosols in medicine (ISAM) during COVID-19: clinical decision makers and governmental agencies should consider the inhaled route of administration: a statement from the ISAM Regulatory and Standardization Issues Networking Group. J Aerosol Med Pulm Drug Deliv 33:235\u2013238. https:\/\/doi.org\/10.1089\/jamp.2020.1622","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"4601_CR114","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/pharmaceutics13071077","volume":"13","author":"BB Eedara","year":"2021","unstructured":"Eedara BB, Alabsi W, Encinas-Basurto D, Polt R, Ledford JG, Mansour HM (2021) Inhalation delivery for the treatment and prevention of COVID-19 infection. Pharmaceutics 13:1077. https:\/\/doi.org\/10.3390\/pharmaceutics13071077","journal-title":"Pharmaceutics"},{"key":"4601_CR115","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40364-019-0159-x","volume":"7","author":"K Yin","year":"2019","unstructured":"Yin K, Wang S, Zhao RC (2019) Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm. Biomark Res 7:8. https:\/\/doi.org\/10.1186\/s40364-019-0159-x","journal-title":"Biomark Res"},{"key":"4601_CR116","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1152\/physiol.00045.2018","volume":"34","author":"PD Stahl","year":"2019","unstructured":"Stahl PD, Raposo G (2019) Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology (Bethesda, Md.) 34:169\u2013177. https:\/\/doi.org\/10.1152\/physiol.00045.2018","journal-title":"Physiology (Bethesda, Md.)"},{"key":"4601_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02663","author":"MO Gomzikova","year":"2019","unstructured":"Gomzikova MO, James V, Rizvanov AA (2019) Therapeutic application of mesenchymal stem cells derived extracellular vesicles for immunomodulation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.02663","journal-title":"Front Immunol"},{"key":"4601_CR118","doi-asserted-by":"publisher","first-page":"109865","DOI":"10.1016\/j.mehy.2020.109865","volume":"144","author":"MH MahsaTaghavi-Farahabadia","year":"2020","unstructured":"MahsaTaghavi-Farahabadia MH, Mahmoudib M, Soudic S, Hashemi SM (2020) Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Med Hypotheses 144:109865","journal-title":"Med Hypotheses"},{"key":"4601_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01648","author":"S Bhaskar","year":"2020","unstructured":"Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S (2020) Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium Position Paper. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01648","journal-title":"Front Immunol"},{"key":"4601_CR120","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/stem.2730","volume":"36","author":"MT Harting","year":"2018","unstructured":"Harting MT, Srivastava AK, Zhaorigetu S, Bair H, Prabhakara KS, Toledano Furman NE, Vykoukal JV, Ruppert KA, Cox CS, Olson SD (2018) Inflammation-stimulated mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation. Stem Cells 36:79\u201390. https:\/\/doi.org\/10.1002\/stem.2730","journal-title":"Stem Cells"},{"key":"4601_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0774-8","author":"M Khatri","year":"2018","unstructured":"Khatri M, Richardson LA, Meulia T (2018) Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. https:\/\/doi.org\/10.1186\/s13287-018-0774-8","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2022.106999","volume":"145","author":"J Burrello","year":"2022","unstructured":"Burrello J, Caporali E, Gauthier LG, Pianezzi E, Balbi C, Rigamonti E, Bolis S, Lazzarini E, Biemmi V, Burrello A, Frigerio R, Martinetti G, Fusi-Schmidhauser T, Vassalli G, Ferrari E, Moccetti T, Gori A, Cretich M, Melli G, Monticone S, Barile L (2022) Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles. Vascul Pharmacol 145:106999. https:\/\/doi.org\/10.1016\/j.vph.2022.106999","journal-title":"Vascul Pharmacol"},{"key":"4601_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103369","volume":"67","author":"C Balbi","year":"2021","unstructured":"Balbi C, Burrello J, Bolis S, Lazzarini E, Biemmi V, Pianezzi E, Burrello A, Caporali E, Grazioli LG, Martinetti G, Fusi-Schmidhauser T, Vassalli G, Melli G, Barile L (2021) Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection. EBioMedicine 67:103369. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103369","journal-title":"EBioMedicine"},{"key":"4601_CR124","doi-asserted-by":"publisher","unstructured":"Ivashchenko ARakhmetullina A, Aisina D (2020) How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV. https:\/\/doi.org\/10.21203\/rs.3.rs-16264\/v1","DOI":"10.21203\/rs.3.rs-16264\/v1"},{"key":"4601_CR125","unstructured":"Expanded access protocol on bone marrow mesenchymal stem cell derived extracellular vesicle infusion treatment for patients with COVID-19 associated ARDS\u2014full text view\u2014ClinicalTrials.gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04657458?term=NCT04657458&draw=2&rank=1. Accessed 23 Apr 2021"},{"key":"4601_CR126","unstructured":"The use of exosomes for the treatment of acute respiratory distress syndrome or novel coronavirus pneumonia caused by COVID-19\u2014tabular view\u2014ClinicalTrials.gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04798716?term=NCT04798716&draw=2&rank=1. Accessed 23 Apr 2021"},{"key":"4601_CR127","unstructured":"NCT05125562, bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment for mild-to-moderate COVID-19: a Phase II clinical trial\u2014full text view\u2014ClinicalTrials.gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05125562?term=NCT05125562&draw=2&rank=1. Accessed 28 Dec 2021"},{"key":"4601_CR128","unstructured":"NCT05116761, ExoFloTM infusion for post-acute COVID-19 and chronic post-COVID-19 syndrome\u2014full text view\u2014ClinicalTrials.gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05116761?term=NCT05116761&draw=2&rank=1. Accessed 28 Dec 2021"},{"key":"4601_CR129","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/sctm.18-0087","volume":"7","author":"L Rohani","year":"2018","unstructured":"Rohani L, Johnson AA, Naghsh P, Rancourt DE, Ulrich H, Holland H (2018) Concise review: molecular cytogenetics and quality control: clinical guardians for pluripotent stem cells. Stem Cells Transl Med 7:867\u2013875. https:\/\/doi.org\/10.1002\/sctm.18-0087","journal-title":"Stem Cells Transl Med"},{"key":"4601_CR130","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA (2015) Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 3:24\u201332. https:\/\/doi.org\/10.1016\/S2213-2600(14)70291-7","journal-title":"Lancet Respir Med"},{"key":"4601_CR131","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/humrep\/DEG143","volume":"18","author":"G de Wert","year":"2003","unstructured":"de Wert G, Mummery C (2003) Human embryonic stem cells: research, ethics and policy. Hum Reprod 18:672\u2013682. https:\/\/doi.org\/10.1093\/humrep\/DEG143","journal-title":"Hum Reprod"},{"key":"4601_CR132","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13287-019-1404-9","volume":"10","author":"N Liao","year":"2019","unstructured":"Liao N, Shi Y, Zhang C, Zheng Y, Wang Y, Zhao B, Zeng Y, Liu X, Liu J (2019) Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion. Stem Cell Res Ther 10:306. https:\/\/doi.org\/10.1186\/s13287-019-1404-9","journal-title":"Stem Cell Res Ther"},{"key":"4601_CR133","doi-asserted-by":"publisher","first-page":"15673","DOI":"10.1073\/pnas.1922535117","volume":"117","author":"M Mushtaq","year":"2020","unstructured":"Mushtaq M, Kovalevska L, Darekar S, Abramsson A, Zetterberg H, Kashuba V, Klein G, Arsenian-Henriksson M, Kashuba E (2020) Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18\u20132. Proc Natl Acad Sci USA 117:15673\u201315683. https:\/\/doi.org\/10.1073\/pnas.1922535117","journal-title":"Proc Natl Acad Sci USA"},{"key":"4601_CR134","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdsr.2017.10.001","volume":"54","author":"N Chosa","year":"2018","unstructured":"Chosa N, Ishisaki A (2018) Two novel mechanisms for maintenance of stemness in mesenchymal stem cells: SCRG1\/BST1 axis and cell\u2013cell adhesion through N-cadherin. Jpn Dent Sci Rev 54:37\u201344. https:\/\/doi.org\/10.1016\/j.jdsr.2017.10.001","journal-title":"Jpn Dent Sci Rev"},{"key":"4601_CR135","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.21906","volume":"8","author":"M Oeller","year":"2018","unstructured":"Oeller M, Laner-Plamberger S, Hochmann S, Ketterl N, Feichtner M, Brachtl G, Hochreiter A, Scharler C, Bieler L, Romanelli P, Couillard-Despres S, Russe E, Schallmoser K, Strunk D (2018) Selection of tissue factor-deficient cell transplants as a novel strategy for improving hemocompatibility of human bone marrow stromal cells. Theranostics 8:1421\u20131434. https:\/\/doi.org\/10.7150\/thno.21906","journal-title":"Theranostics"},{"key":"4601_CR136","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z (2019) Stem cells: past, present, and future. Stem Cell Res Ther 10:68. https:\/\/doi.org\/10.1186\/s13287-019-1165-5","journal-title":"Stem Cell Res Ther"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04601-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T17:08:15Z","timestamp":1684948095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04601-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":136,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4601"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04601-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}